Anticholinergic drugs, buccal ulceration and mucosal potential difference

Area of Science:

• Pharmacology
• Biomedical Engineering
• Toxicology

Background:

• Assessing the safety of drug formulations is crucial.
• Buccal mucosa is a common route for drug delivery.
• Predicting mucosal toxicity and ulcerogenic potential is essential for drug development.

Observation:

• Changes in buccal mucosal potential difference (BMPD) were measured.
• Drug formulations were applied to the buccal mucosa.
• The correlation between BMPD changes and mucosal damage was observed.

Findings:

• Measurement of BMPD changes effectively predicts mucosal toxicity.
• BMPD alterations correlate with ulcerogenic activity of drug formulations.
• This technique offers a quantitative method for safety assessment.

Implications:

• This method can improve the safety profiling of new drug formulations.
• It may reduce the need for animal testing in preclinical safety assessments.
• Early prediction of toxicity can accelerate drug development and reduce costs.